ArticleJournal of toxicologic pathology2026

Evaluation of the skin carcinogenicity of the TRPV1 antagonist motugivatrep (SJP-0132) using an ultra-short-term two-stage skin carcinogenesis assay in Tg-rasH2 mice.

Yoshinori Yamagiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.